Evidence map›Paper›PMID 42827750›Full record

ArticleOncology letters2026

MAD2L1 overexpression promotes breast cancer progression and confers resistance to paclitaxel via proteasomal stabilization.

Shih-Ho Wang, Cheng-Hsi Yeh, Chia-Wei Wu, Chia-Yi Hsu, Eing-Mei Tsai, Chao-Ming Hung, Ming-Wei Lin, Tsung-Hua Hsieh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shih-Ho WangDivision of General Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan, R.O.C.
Cheng-Hsi YehDivision of General Surgery, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan, R.O.C.
Chia-Wei WuDepartment of Medical Research, E-Da Cancer Hospital, I-Shou University, Kaohsiung 82445, Taiwan, R.O.C.
Chia-Yi HsuDepartment of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan, R.O.C.
Eing-Mei TsaiDepartment of Obstetrics and Gynecology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80756, Taiwan, R.O.C.
Chao-Ming HungDepartment of Surgery, E-Da Cancer Hospital, I-Shou University, Kaohsiung 82445, Taiwan, R.O.C.
Ming-Wei LinDepartment of Medical Research, E-Da Cancer Hospital, I-Shou University, Kaohsiung 82445, Taiwan, R.O.C.
Tsung-Hua HsiehDepartment of Medical Research, E-Da Cancer Hospital, I-Shou University, Kaohsiung 82445, Taiwan, R.O.C.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitotic arrest deficiency protein 2-like 1 (MAD2L1) is a notable component of the spindle assembly checkpoint that ensures proper chromosome segregation during mitosis. Analysis of The Cancer Genome Atlas breast cancer datasets revealed that

Indexed as

breast cancerMAD2L1paclitaxel

Identifiers

PMID42827750
PMCPMC13631639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.